TRVI
Trevi Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 67.23M | $1.24B | +8 | −8 |
| Q1 2026 | 77 | +2 | 59.43M | $710.63M | +8 | −6 |
| Q4 2025 | 75 | 0 | 58.45M | $731.74M | +1 | −1 |
| Q3 2025 | 18 | 0 | 44.17M | $404.20M | — | — |
| Q2 2025 | 15 | 0 | 25.58M | $139.93M | +1 | −1 |
| Q1 2025 | 12 | 0 | 12.85M | $80.81M | +1 | −1 |
| Q4 2024 | 12 | +4 | 15.26M | $62.88M | +4 | — |
| Q3 2024 | 7 | +3 | 5.91M | $19.73M | +3 | — |
| Q2 2024 | 4 | — | 5.62M | $16.74M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 4.40M | 0.0% | $18.13M | 0.1% | Held | 3 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 4.15M | New | $17.10M | 0.0% | New | 1 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 2.50M | New | $10.30M | 0.0% | New | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.30M | +2.8% | $5.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.30M | +2.8% | $5.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.23M | +2372.2% | $5.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.23M | +2372.2% | $5.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passive) | 1.17M | — | $4.82M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 180.42K | +774.9% | $743,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 135.81K | New | $559,525 | 0.0% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 100.40K | +42.0% | $413,648 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 42.92K | -47.1% | $176,835 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 25.17K | +32.1% | $104,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 23.03K | New | $94,892 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 23.03K | New | $94,892 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $17.10M | 0.0% |
| Adage Capital Partners | $10.30M | 0.0% |
| Two Sigma Investments | $559,525 | 0.0% |
| AQR Capital Management | $94,892 | 0.0% |
| AQR Capital Management | $94,892 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 198 holders, 134.86M shares, $1.61B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.